Early biologic treatment in Crohn’s Disease: Shining a light on SEAVUE


Learning objectives:

After this event, participants should be able to:

  • Determine how the management of CD is evolving and how to select targets and optimize treatment strategies in CD
  • Discuss the results of the SEAVUE trial
  • Examine the implications of the SEAVUE trial on management strategies for CD



  • Matthieu Allez, France
  • Silvio Danese, Italy
  • Peter Irving, UK

More Info
1 Hours
EM-59844 - Date of preparation: April 2021